Nexalis Therapeutics Limited (ASX:NX1)

Nexalis Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.44	0.19	0.72	2.13	2.8
Cash & Short-Term Investments	0.44	0.19	0.72	2.13	2.8
Cash Growth	124.15%	-72.77%	-66.45%	-23.90%	63.04%
Accounts Receivable	0.69	-	-	-	-
Other Receivables	-	0.45	0.8	0.03	0.02
Receivables	0.69	0.45	0.8	0.03	0.02
Inventory	-	-	-	-	0.02
Prepaid Expenses	0.08	0.07	0.06	0.08	0.06
Other Current Assets	-	-	-	-	0
Total Current Assets	1.21	0.71	1.58	2.24	2.91
Property, Plant & Equipment	-	-	-	-	0.01
Other Intangible Assets	-	-	-	0.01	0.01
Total Assets	1.21	0.71	1.58	2.26	2.93
Accounts Payable	1.64	0.57	0.18	0.12	0.07
Accrued Expenses	0	-	0	0	-
Short-Term Debt	0.43	0.03	0.56	-	-
Current Unearned Revenue	-	-	-	-	0.02
Other Current Liabilities	-	0.17	0.17	0.23	0.16
Total Current Liabilities	2.07	0.78	0.91	0.36	0.25
Long-Term Debt	0.32	-	-	-	-
Pension & Post-Retirement Benefits	0	0	0	-	-
Total Liabilities	2.38	0.78	0.91	0.36	0.25
Common Stock	15.15	14.53	14.08	13.93	12.9
Retained Earnings	-16.21	-14.38	-13.17	-11.73	-9.25
Comprehensive Income & Other	-0.12	-0.21	-0.24	-0.3	-0.97
Shareholders' Equity	-1.18	-0.06	0.67	1.9	2.68
Total Liabilities & Equity	1.21	0.71	1.58	2.26	2.93
Total Debt	0.74	0.03	0.56	-	-
Net Cash (Debt)	-0.3	0.16	0.16	2.13	2.8
Net Cash Growth	-	3.41%	-92.71%	-23.90%	63.04%
Net Cash Per Share	-0.00	0.00	0.00	0.01	0.02
Filing Date Shares Outstanding	217.98	213.45	189.77	187.27	168.47
Total Common Shares Outstanding	217.98	213.45	189.77	187.27	168.47
Working Capital	-0.86	-0.06	0.67	1.89	2.65
Book Value Per Share	-0.01	-0.00	0.00	0.01	0.02
Tangible Book Value	-1.18	-0.06	0.67	1.89	2.66
Tangible Book Value Per Share	-0.01	-0.00	0.00	0.01	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.